|
|
Volumn 347, Issue 7918, 2013, Pages
|
|
What does oseltamivir do, and how will we know?
a
a
BMJ
*
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
OSELTAMIVIR;
PLACEBO;
VIRUS ANTIBODY;
2009 H1N1 INFLUENZA;
ANTIBODY TITER;
CLINICAL ASSESSMENT;
CLINICAL DECISION MAKING;
CONSENSUS;
DRUG APPROVAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESEARCH;
EVIDENCE BASED MEDICINE;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS;
NONHUMAN;
OBSERVATIONAL STUDY;
PANDEMIC INFLUENZA;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SEASONAL INFLUENZA;
SHORT SURVEY;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
ANTIVIRAL AGENTS;
HUMANS;
INFLUENZA, HUMAN;
META-ANALYSIS AS TOPIC;
OSELTAMIVIR;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REVIEW LITERATURE AS TOPIC;
|
|
EID: 84880857578
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f4687 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (1)
|
